0604 pub planning
Transcription
0604 pub planning
SPECIAL ISSUE July/August 2010 THE FORUM FORTHE INDUSTRY EXECUTIVE 100 of the Most Inspiring People P U B L I C AT I O N www.pharmavoice.com Letter from the EDITOR THE FORUM FOR THE INDUSTRY EXECUTIVE The PharmaVOICE 100: 2010 Volume 10 • Number 7 PUBLISHER EDITOR CREATIVE DIRECTOR Lisa Banket Taren Grom Marah Walsh MANAGING EDITOR Denise Myshko SENIOR EDITOR Robin Robinson FEATURES EDITOR Kim Ribbink CONTRIBUTING EDITOR Carolyn Gretton DESIGN ASSOCIATE Ariel Medel NATIONAL ACCOUNT MANAGER Cathy Tracy CIRCULATION ASSISTANT Kathy Deiuliis Copyright 2010 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Ten, Number Seven PharmaVOICE (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by PharmaLinx LLC, P.O. Box 327, Titusville, NJ 08560. Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices. Postmaster: Send address changes to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345. PharmaVOICE Coverage and Distribution: Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVOICE at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197. Contributions: PharmaVOICE is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVOICE retains all rights on material published in PharmaVOICE for a period of six months after publication and reprint rights after that period expires. E-mail: [email protected]. Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: [email protected]. IMPORTANT NOTICE: The post office will not forward copies of this magazine. PharmaVOICE is not responsible for replacing undelivered copies due to lack of or late notification of address change. Advertising in PharmaVOICE: To advertise in PharmaVOICE please contact our Advertising Department at P.O. Box 327, Titusville, NJ 08560, or telephone us at 609.730.0196. E-mail: [email protected]. Letters Send your letters to [email protected]. Please include your name, title, company, and business phone number. Letters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC. Printed on recycled paper Every year, I think this is it, we’ve reached the pinnacle. And yet, every year, I continue to be amazed by the individuals whom our readers have identified as the most inspiring, motivating, and outstanding leaders in the life-sciences industry. This special issue, now in its sixth year, has become a must-read and one of the most-anticipated publications of the year. It is our extreme pleasure to once again be able to pay tribute to the men and women who are driving change, providing guidance, and fostering relationships to position the industry in the best way possible to serve the ultimate stakeholders: patients. The individuals featured in this issue are as diverse in their talents, skills, and know-how as their roots.They come from around the United States and around the world — Argentina, Australia, Canada, China, Cuba, England, France, India, Ireland, Italy, Malaysia, Nigeria, and Zimbabwe — to name just a few of their countries of origin.This broad geographic representation is a testament to not only how global the life-sciences industry has become, but how easy it is to transcend national borders through positive actions that influence others in a meaningful and substantive way.We are equally delighted that PharmaVOICE’s reach allows us to bring you their stories. This special publication, which has become known as the feel-good issue of the year, is packed with in-depth profiles showcasing the industry’s best and brightest.To make the issue easier to navigate, we have divided the honorees into categories that we think best capture their expertise. Please note, however, that most of this year’s honorees could easily fit into several of the following sections: commanders and chiefs, entrepreneurs, change agents, clinical specialists, researchers and scientists, marketers, creatives, mentors, and technologists. In spite of shifting market landscapes, uncertain business conditions, and reduced headcounts, these industry leaders are overcoming myriad obstacles as they set the gold standard for corporate leadership, cutting-edge research and development, forward-thinking technology solutions, out-of-the-box creative executions and marketing strategies, and outstanding career development training processes. Not only are the honorees contributing to the growth of their organizations, they are community leaders and serve as members of industry-related associations and donate time to worthy charities and philanthropic organizations. Each year the selection process becomes more difficult.With thousands of nominations to consider, our editorial team relies on the personal stories and accounts that describe why these individuals are special.We want to thank all of our readers who took time out of their busy schedules to nominate those who have made, and continue to make, a difference in their careers, lives, and organizations.The quality and number of nominations received this year reaffirms that the industry is driven by people of vision and passion who are dedicated to improving healthcare and patients’ lives. We also want to thank all of our PharmaVOICE 100 honorees for taking time to share their personal stories with us.These insights provided our team with a wealth of information on which to base this year’s profiles. Please join us in extending warm congratulations to this august group as we celebrate the well-deserving individuals featured in this sixth annual PharmaVOICE 100 issue. I hope you enjoy getting to know this distinguished group as much as we did. And don’t forget to check out the exclusive bonus text found only in our digital edition, which can be accessed at pharmavoice.com, to read more of their stories. We can’t wait to see who makes next year’s list. Submit your nominations for 2011 now! The Change AGENTS DR. LEO FRANCIS ENERGY AND IDEAS IGNITED IT WAS APPARENT FROM THE START OF HIS CAREER THAT LEO FRANCIS, PH.D.,WAS A LEADER IN THE MAKING. FROM HIS EARLY DAYS IN THE INDUSTRY, DR. FRANCIS’ PROFESSIONALISM AND INEXORABLE DRIVE FOR EXCELLENCE IN ALL ASPECTS OF HIS WORK HAVE SHONE THROUGH. His achievements have led to extraordinary progressions up the corporate ladder in different fields within the industry and in each position of increasing responsibility he has won the praise of his peers and reports through consistent displays of business success and effective leadership. Clients and co-workers alike love working with Dr. Francis because of his positive outlook and contagious laugh, his vision, and his ability to motivate through persuasion not intimidation. What makes Dr. Francis stand out is his willingness to make unorthodox decisions. For example, when preparing to make a critical presentation to a potential client while at a former employer, he surmised that his team wouldn’t be ready on the scheduled date. Rather than leave the date in place and hope for the best, he went in person to the client and asked for a postponement. The team made the presentation at a later date and the company got the account. His position as president of the Publicis Medical Education Group (PMEG) provides a global pulpit and access to key leaders who are infected and affected by his energy and ideas. Always on the lookout for the next frontier of medical education, his prescience and foresight have supported a surge in the use of digital technology as a key resource in globalizing medical education and advancing healthcare. He set the goal to make PMEG a group of next-generation medical education companies that use digital technology tools for collaboration, information exchange, and knowledge transfer to optimally deliver value-added services that empower healthcare professionals and patients with knowledge, information, and awareness, ultimately creating a higher level of healthcare service and performance. A strong proponent of the patient’s role in Dr. Leo Francis, President of Publicis Medical Education, is evangelistic in his enthusiasm and passion for developing team members to become leaders in the field. DID YOU KNOW? Charismatic.Visionary. NAME: Leo P. Francis, Ph.D. CURRENT POSITION: President, Publicis Medical Education Group EDUCATION: Ph.D., University of Central In 2009, Dr. Leo Francis scored two of the three winning goals for his soccer team in the MCSSA state summer league championship final. Lancashire; B.Sc., Bristol Polytechnic ? PLACE OF BIRTH: Birmingham, U.K. FIRST JOB: Newspaper delivery boy FIRST INDUSTRY-RELATED JOB: Clinical research associate, Gensia Europe Ltd. DREAM JOB: Philanthropist healthcare, Dr. Francis is a vocal and effective advocate for education to improve outcomes and create value. His vision for the world of medical education and his ability to articulate its importance to the health and wellness dialogue are inspiring. For Dr. Francis, it’s all about inspiring his leadership team to be better managers not only to ensure the success of the staff members they lead but to truly make a difference in healthcare. He inspires his colleagues to think about the current climate as an opportunity to improve the status quo, and his actions support his philosophy. Dr. Francis has created focused brand development and messaging campaigns across several therapeutic areas, including cardiovascular, neurology, psychiatry, and anti-infectives. He has also published extensively in peerreviewed scientific journals. PharmaVOICE PROFESSIONAL MENTOR: Dr. Dennis N. Joseph, former boss PROFESSIONAL ASSOCIATION: Healthcare Businesswomen’s Association CONNECTED VIA: LinkedIn, Plaxo, Naymz, Facebook WORDS TO LIVE BY: Looking good, feeling good; and do what you say July/August 2010 3 The Change AGENTS DR. LEO FRANCIS • IMAGINING THE POSSIBLE Getting Personal with DR. LEO FRANCIS FAMILY: Wife, Lyn; Son, Isaac INSPIRATION: His family, Martin Luther King, READING LIST: The American Constitution; Money Ball by Gandhi, Nelson Mandela Michael Lewis;The Winning Edge by George Alston; AutoWeek; Business: 1001 Ways to Reward Employees by Bob Nelson;The Power of Learning by Klas Mellander TOP IPOD DOWNLOADS: R&B and Jazz, Ashanti, Kenny HOBBIES: Martial arts, soccer, fitness training, performance sports cars, dining out, collecting watches GIVING BACK: Community volunteer for U.K.-based mentor Lattimore,Will Downing LIFE LESSONS: Be true to and believe in yourself A LITTLE KNOWN FACT: Until the age of 20, he played high-level competitive cricket project UNDER THE CLOAK OF INVISIBILITY: Visit No. 10 Downing St. BUCKET LIST: Own a Lamborghini; live to at least 100 and The White House With equal command of science and business, Leo Francis, Ph.D., is able to provide exemplary leadership to his employees, colleagues, and friends. A driven and energized leader, Dr. Francis believes everything is possible and will not stop until the goal is achieved. His enthusiasm ignites all those around him, co-workers and clients alike, and he encourages people to go the extra mile. A forward-thinking leader, Dr. Francis never settles for the standard or the norm, but constantly pushes himself and others to think bigger, go farther, and try something new. Since joining Publicis Medical Education Group in January 2008, he has quickly and adeptly assumed the role of go-to counselor for clients and staff. In two short years as president, Dr. Francis has driven strong organiza- tion growth, significantly improved staff retention rates, diversified the company’s client base, instilled a nurturing culture of excellence, and brought about transformational perspectives from digital to metrics in communications. A skilled team builder, he recently set up a cross-functional meeting to engage people to discuss what they believe are the future trends; he believes vision is developed and owned by everyone. He also has a great ability to remain calm under pressure, and he is always clear and concise about his vision and expectations. With an extraordinary ability to create meaningful and caring relationships with all he encounters, Dr. Francis will go out of his way to help others, listen to other points of view, and be open to new ideas. While he expects the best from his staff, he 4 PharmaVOICE July/August 2010 does so in a way that is and non-threatening empowering. Titles are not important to Dr. Francis, who treats everyone with the same respect, and is present and engaged with everyone with whom he interacts. Dr. Francis cares deeply about how employees are engaged, motivated, and involved in their roles, and continuously provides direct and honest feedback to everyone. When there is a win, no matter how big or how small, Dr. Francis is one of the first to send his note of gratitude and appreciation for the accomplishment. Dr. Francis believes that when others excel, he excels, and that the collective commitment and sharing of knowledge create positive outcomes in work and in life. He is a strong supporter of the HBA, and members of his leadership team are active and senior participants in the organization — from regional chapter groups to HBA board memberships. While excelling in the workplace, Dr. Francis understands the importance of balancing work with personal life. Time outside of the office is devoted to his wife Lyn, family, and Dr. Francis is deeply in helping his son with schoolwork and on the soccer field. ✦ The PharmaVOICE 100 WHO’S ON THE LIST — 2010 Anavex Life Sciences . . . . . . . . . . .Cameron Durrant, M.D. ApotheCom . . . . . . . . . . . . . . . . . . . . .David Dunn Astellas Pharma US . . . . . . . . . . . . .Margaret Long AstraZeneca . . . . . . . . . . . . . . . . . . . .David Brennan bioCapture . . . . . . . . . . . . . . . . . . . . . .Johanna Allston, Ph.D. C3i . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Robert Piwko Cegedim Dendrite . . . . . . . . . . . . . .Angela Miccoli Cipla Ltd. . . . . . . . . . . . . . . . . . . . . . . . .Yusuf Hamied, Ph.D. ClearTrial . . . . . . . . . . . . . . . . . . . . . . . .Mike Soenen closerlook . . . . . . . . . . . . . . . . . . . . . .David Ormesher Cognizant . . . . . . . . . . . . . . . . . . . . . .Nagarajan Srivatsan Complete Genomics . . . . . . . . . . . .Clifford Reid, Ph.D. Daiichi Sankyo . . . . . . . . . . . . . . . . . .Joe Pieroni Delta Pharma . . . . . . . . . . . . . . . . . . .Christina Fleming, Ph.D. Derycz Scientific . . . . . . . . . . . . . . . .Peter Derycz Diagnostics for All . . . . . . . . . . . . . . .Una Ryan, Ph.D. DWA Healthcare Communications Group . . . . . .Deborah Wood Echo Torre Lazur . . . . . . . . . . . . . . . .Bill McEllen eClinical Solutions . . . . . . . . . . . . . .Susan Bornstein EMD Serono . . . . . . . . . . . . . . . . . . . .James Hoyes Epocrates . . . . . . . . . . . . . . . . . . . . . . .Rose Crane eResearch Technology . . . . . . . . . .Joel Morganroth, M.D. Excel Life Sciences . . . . . . . . . . . . . .Vijai Kumar, M.D. Fate Therapeutics . . . . . . . . . . . . . . .Sheng Ding, Ph.D. FDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Michael Marcarelli, Pharm.D. Firecrest Clinical . . . . . . . . . . . . . . . .Brendan Buckley, M.D., D.Phil. Genentech . . . . . . . . . . . . . . . . . . . . .Carol Wells GeoVax . . . . . . . . . . . . . . . . . . . . . . . . .Robert McNally, Ph.D. Group DCA . . . . . . . . . . . . . . . . . . . . . .Rob Likoff GSW . . . . . . . . . . . . . . . . . . . . . . . . . . . .Bruce Rooke Halloran Consulting Group . . . . . .Laurie Halloran Harrison & Star . . . . . . . . . . . . . . . . . .Larry Star Healthy Advice Networks . . . . . . .Tom Campbell Horizon Pharma . . . . . . . . . . . . . . . . .Tim Walbert HRA Pharma . . . . . . . . . . . . . . . . . . . .Erin Gainer, Ph.D. Humedica . . . . . . . . . . . . . . . . . . . . . .Michael Weintraub i3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Glenn Bilawsky iGuard.org, a Quintiles Co. . . . . . . .Hugo Stephenson, M.D. INC Research . . . . . . . . . . . . . . . . . . . .Silvia Zieher, M.D. Intouch Solutions . . . . . . . . . . . . . . .Wendy Blackburn ISTA Pharmaceuticals . . . . . . . . . . .Vicente Anido Jr., Ph.D. Johnson & Johnson . . . . . . . . . . . . .Alex Gorsky Johnson & Johnson . . . . . . . . . . . . .Kevin Scott Kantar Health . . . . . . . . . . . . . . . . . . .Lynnette Cooke Kendle . . . . . . . . . . . . . . . . . . . . . . . . . .Candace Kendle, Pharm.D. Leslie Gaber Associates . . . . . . . . .Leslie Gaber Lux Capital Management . . . . . . .Robert Paull MannKind . . . . . . . . . . . . . . . . . . . . . . .Alfred Mann The Medical Affairs Company . . . . . . . . . . . . . . . . . . . . .Jennifer King MediciGlobal . . . . . . . . . . . . . . . . . . . .Nick Halkitis Medicus Life Brands . . . . . . . . . . . . .Lisa Ebert Medidata Solutions Worldwide . . . . . . . . . . . . . . . . . . .Graham Bunn, Ph.D. Indexed by Company Affiliation Merck . . . . . . . . . . . . . . . . . . . . . . . . . . .Jeff Berkowitz Merck . . . . . . . . . . . . . . . . . . . . . . . . . .Richard Branton MicroMass Communications . . . . . . . . . . . . .Jamie Cobb Millennium:The Takeda Oncology Co. . . . . . . . . . . . . . . . . .Deborah Dunsire, M.D. Nigerian NAFDAC . . . . . . . . . . . . . . .Paul Orhii, M.D., Ph.D. Novartis . . . . . . . . . . . . . . . . . . . . . . . .David Epstein Novartis . . . . . . . . . . . . . . . . . . . . . . . . .Joe Jimenez Novartis . . . . . . . . . . . . . . . . . . . . . . . .Ted White Oceana Therapeutics . . . . . . . . . . .John Spitznagel Octagon Research Solutions . . . .James Walker Ogilvy CommonHealth . . . . . . . . .Scott Watson Omnicare Clinical Research . . . . .James Pusey, M.D. On-Q-ity . . . . . . . . . . . . . . . . . . . . . . . .Mara Aspinall Outcome . . . . . . . . . . . . . . . . . . . . . . . .Richard Gliklich, M.D. Palio . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dan Bobear Pfizer (formerly) . . . . . . . . . . . . . . . . .Mohan Bangalore, Ph.D. Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . .Craig Lipset Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . . .Paulash Mohsen Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . .Joe Shields PharmaNet . . . . . . . . . . . . . . . . . . . . .Jeff Trotter PHT Corp. . . . . . . . . . . . . . . . . . . . . . . .Barbara Marino, Ph.D. Physicians Interactive . . . . . . . . . . .Devin Paullin Pink Tank . . . . . . . . . . . . . . . . . . . . . . . .Marcee Nelson PPD . . . . . . . . . . . . . . . . . . . . . . . . . . . .Randy Anderson, Ph.D. Publicis Healthcare Communications Group . . . . . .Nick Colucci Publicis Medical Education . . . . . .Leo Francis, Ph.D. Publicis Touchpoint Solutions . . . . . . . . . . . . . . . . . . . . .Rick Keefer Purohit Navigation . . . . . . . . . . . . . .Ahnal Purohit, Ph.D. Qforma . . . . . . . . . . . . . . . . . . . . . . . . .Alan Reicheg QPharma . . . . . . . . . . . . . . . . . . . . . . .Jeff Boatman Quotient Bioresearch . . . . . . . . . . .Peter Scholes, Ph.D. Regan Campbell Ward Group . . . . . . . . . . . . . . . . . . . . . . . .Dan Hassan Roche . . . . . . . . . . . . . . . . . . . . . . . . . . .Maryann Szabo Roska Healthcare . . . . . . . . . . . . . . .Jay Bolling Sanofi-Aventis . . . . . . . . . . . . . . . . . . .Michael Agard Sanofi-Aventis . . . . . . . . . . . . . . . . . . .Chris Viehbacher Shire Human Genetic Therapies . . . . . . . . . . . .William Ciambrone Snow Companies . . . . . . . . . . . . . . .Brenda Snow Torre Lazur McCann . . . . . . . . . . . .Joanne Duckman UBC . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Chad Clark Unigene Laboratories . . . . . . . . . . .Warren Levy, Ph.D. Veeva Systems . . . . . . . . . . . . . . . . . .Peter Gassner Venn Life Sciences . . . . . . . . . . . . . .Marlene Llopiz-Aviles, M.D. Verilogue . . . . . . . . . . . . . . . . . . . . . . .Jeff Kozloff Vertex Pharmaceuticals . . . . . . . . .Craig Sorensen, Ph.D. Wishbone . . . . . . . . . . . . . . . . . . . . . .Steve Hamburg Wolfe Laboratories . . . . . . . . . . . . . .Janet Wolfe, Ph.D. Y Brand . . . . . . . . . . . . . . . . . . . . . . . . .Vince Parry PharmaVOICE David Brennan AstraZeneca Angela Miccoli Cegedim Dendrite Bill McEllen Echo Torre Lazur James Hoyes EMD Serono Rob Likoff Group DCA Jennifer King The Medical Affairs Company Dr. Graham Bunn Medidata Jamie Cobb MicroMass Communications Dr. Ahnal Purohit Purohit Navigation Joanne Duckman Torre Lazur McCann July/August 2010 5